The status of p53 and MDM4 was not specified in those studies but it is known that the frequency of p53 mutations is high in both cutaneous squamous cell carcinoma (40%-50%) [41] and lung adenocarcinoma (63%) [42]. This evidence concerns the gene MDM4 and lung adenocarcinoma.